Related by context. Frequent words. (Click for all words.) 75 safety tolerability pharmacokinetics 74 pharmacokinetics 72 pharmacodynamics 72 pharmacodynamic 72 tolerability 70 Pharmacokinetic 70 pharmacokinetic profile 70 dose escalation trial 69 tolerated dose MTD 69 pharmacokinetic 69 safety tolerability 68 Phase IIa clinical 68 Phase 1b clinical 68 Phase 2a clinical 68 single ascending dose 67 dose escalation study 67 Phase 1b 67 multiple ascending dose 67 Phase IIa trial 67 Phase Ib 67 efficacy 66 phase 2a 66 Secondary endpoints 65 phase IIb 65 Phase 2b clinical 65 immunogenicity 65 Phase 2b study 65 dosing regimens 65 dose limiting toxicities 64 Secondary endpoints include 64 antiviral activity 64 Phase 2a trial 64 Phase IIa 64 placebo controlled 64 Tolerability 63 antitumor activity 63 label dose escalation 63 Secondary endpoints included 63 tolerability profile 63 vicriviroc 63 IMGN# 63 pharmacokinetic properties 63 antithrombotic 63 Phase IIb clinical 62 PS# [001] 62 CYT# 62 composite endpoint 62 efficacy endpoints 62 investigational oral 62 PXD# 61 NGX# 61 double blind placebo 61 blind randomized placebo 61 Phase 2b trial 61 multicenter randomized double 61 adalimumab 61 mg BID 61 randomized placebo controlled 61 blinded placebo controlled 61 INCB# [002] 61 non inferiority 61 Phase 2b 60 Phase IIb 60 Phase 2a 60 dasatinib 60 blind randomized 60 GRN#L 60 imetelstat 60 PF # [001] 60 ISIS # 60 azacitidine 60 CA4P 60 PK PD 60 Preclinical studies 60 multicentre 60 BAY #-# 60 DB# [003] 60 temsirolimus 59 monotherapy 59 blind placebo controlled 59 HGS ETR1 59 randomized clinical 59 unblinded 59 genotypic 59 AZD# 59 Pharmacokinetics 59 mg dose 59 evaluable patients 59 randomized controlled clinical 59 randomized controlled 59 plasma concentrations 59 tiotropium 59 bosentan 59 metastatic renal cell carcinoma 59 Phase III clinical 59 RG# [001] 59 evaluable 59 mcg kg 59 prospective cohort 59 LEVADEX 59 prespecified